{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-241639","form_type":"8-K","ticker":"EYPT","cik":"0001314102","company_name":"EyePoint, Inc.","filed_at":"2025-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.065346+00:00","generated_at":"2026-05-17T03:21:36.524526+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"EyePoint raises ~$150M in public offering to fund DURAVYU clinical development","bullets":["Pricing: 11M shares at $12.00 each; 1.5M pre-funded warrants at $11.999 each.","Gross proceeds ~$150M; net proceeds after underwriting discounts ~$141M.","Net proceeds to advance DURAVYU for wet AMD and DME, plus pipeline and general purposes.","Underwriters have 30-day option for up to 1,875,000 additional shares at $12.00.","Offering closed on October 16, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-241639","json":"https://secwatch.observer/filing/0001193125-25-241639.json","markdown":"https://secwatch.observer/filing/0001193125-25-241639.md","text":"https://secwatch.observer/filing/0001193125-25-241639.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314102/000119312525241639/0001193125-25-241639-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314102/000119312525241639/d98837d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:21:36.524526+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}